Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | VVD-159642 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on VVD-159642, a putative inhibitor of Ras and Pi3kalpha (Mar 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| VVD-159642 | VVD 159642|VVD159642 | PIK3CA inhibitor 27 RAS Inhibitor (Pan) 13 | Limited information is currently available on VVD-159642, a putative inhibitor of Ras and Pi3kalpha (Mar 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06804824 | Phase I | Sotorasib + VVD-159642 VVD-159642 Trametinib + VVD-159642 | A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors | Recruiting | USA | AUS | 0 |